Company Overview - The company, Hangzhou Gan Zhi Cao Technology Co., Ltd., is a leading online TCM (Traditional Chinese Medicine) comprehensive service provider in China, focusing on online TCM diagnosis and treatment services, TCM medical institution services, and TCM health products [3][4]. - Established in 2015, the company is one of the earliest online TCM service providers in China, holding a market share of 4.9% in the online TCM comprehensive service market, ranking first among its peers [3][4]. Business Model - The company has developed an online diagnosis platform, Gan Cao Doctor, enabling TCM practitioners to provide medical services, and a SaaS and supply chain service system, Gan Cao Cloud Manager, designed for TCM medical institutions [4]. - It has established a smart shared pharmacy network consisting of seven self-operated regional pharmacies, seven joint venture pharmacies, and 52 outsourced pharmacies across China, facilitating the preparation, processing, dispensing, and delivery of TCM [4][5]. Financial Performance - The company's revenue for the nine months ending September 30 for 2023, 2024, and 2025 is approximately RMB 603 million, RMB 690 million, and RMB 554 million, respectively [6]. - The profit and total comprehensive income for the same periods are RMB 1.875 million, RMB 10.156 million, and a loss of RMB 1.235 million [7]. - The gross profit margin for these periods is 22.8%, 23.4%, and 27% [8]. Industry Overview - The TCM industry in China is projected to grow from RMB 1,079.4 billion in 2019 to RMB 1,448.6 billion in 2024, with a compound annual growth rate (CAGR) of 6.1%, and is expected to reach RMB 2,261.5 billion by 2029, with a future five-year CAGR of 9.3% [11]. - The online TCM service market is anticipated to expand significantly, from RMB 2.7 billion in 2019 to RMB 13 billion in 2024, reflecting a CAGR of 36.5% [11][13].